Jpmorgan Chase & CO Outset Medical, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Outset Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,662 shares of OM stock, worth $4,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,662
Previous 15,895
64.38%
Holding current value
$4,642
Previous $10,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding OM
# of Institutions
89Shares Held
19.5MCall Options Held
66.8KPut Options Held
60.3K-
Vanguard Group Inc Valley Forge, PA2.61MShares$2.14 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.89MShares$1.55 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.81MShares$1.48 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA1.47MShares$1.21 Million0.08% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.29MShares$1.06 Million0.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $39.4M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...